Recorded May 16, 2022
Clinical trials can provide the most advanced treatments for CLL / SLL before they are commercially available. Other benefits can include close monitoring by an expert healthcare team and often coverage of the cost of the trial medications and potentially other trial related expenses.
Join CLL Society and Dr. Adrian Wiestner with National Institutes of Health (NIH) and clinical trials nurse Kaitlin Kennard with UPENN to learn more about clinical trials, who should consider participating, what questions you should ask, and your rights. Christina Rodriguez Fuller will share her experience in a clinical trial as part of her frontline treatment for CLL.
Welcome:
Robyn Brumble
Director of Scientific Affairs
CLL Society
Speakers:
Moderator
Brian Koffman, MDCM (retired), MS Ed
Co-Founder, Executive Vice President, and Chief Medical Officer
CLL Society
Speaker
Adrian Wiestner, MD, PhD
Senior Investigator
Laboratory of Lymphoid Malignancies
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
Speaker
Kaitlin Kennard, BSN, RN
CLL Program Nurse
Center for Chronic Lymphocytic Leukemia
Penn Medicine’s Abramson Cancer Center
Speaker
Christina Rodriguez Fuller
CLL Patient Advocate
CLL Society Resources
This program was made possible by grant support from AstraZeneca, Pharmacyclics, Janssen, and BeiGene.
